DOXYCYCLINE HYCLATE Recall D-1054-2022
Description: Doxycycline Hyclate Tablets, USP, 100 mg, 50-count carton (10 tablets each blister pack x 5), Rx only, MFG: Major Pharma, NDC 0904-0430-06
DOXYCYCLINE HYCLATE Recall D-1054-2022 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-1054-2022 |
| Event ID | 89646 |
| Brand | DOXYCYCLINE |
| Generic Name | DOXYCYCLINE HYCLATE |
| Manufacturer | DOXYCYCLINE HYCLATE |
| Active Substance | DOXYCYCLINE HYCLATE |
| Drug Route | ORAL |
| Distribution | USA nationwide. |
| Quantity | 108 cartons/50 blisters per carton |
| Recall Reason | cGMP deviations: Temperature abuse |
| Drug Classification | Class II |
| Drug Code Info | 20220615 |
| Product NDC | 0904-0430 |
| Recall Initiation Date | 20220413 |
| Report Date | 20220615 |
| Classification Date | 20220609 |
| Address | 9954 Maryland DriveDeep Run Iii Ste. 4000 Richmond, VA 23233 United States |
| Recalling Firm | Mckesson Medical-Surgical Inc. Corporate Office |
| Initial Notification | Letter |
| Unique Ingredient Identifier | 19XTS3T51U |
| Drug Application Number | ANDA065095 |
| Structured Product Labeling (SPL ID) | a43d088c-e5b1-4bff-ac7e-e4641f0dabba |
| Structured Product Labeling (SPL Set ID) | e7c14a8e-c713-4f03-94e8-1ec9ae077d4d |
| Similar To |